PDA The Future of Drug Delivery Workshop 2024

Featured Presenters

• 

  Eric Chanie

  Merck Group

  Read Bio

  

  Eric Chanie

  Merck Group

  After an electronic engineering degree in France complemented by an MBA in Marketing, Eric Chanie joined a start-up company as Research & Development director involved in gas analysis for odor measurement. The company grew from 3 people to more than 100 with a successful IPO on the Paris stock exchange. In 2007, He then joined a medical device company developing miniaturized sensors for hemodialysis and neurosurgery (biosensing, intracranial pressure measurement) in which he leads the Research and Development team. He joined Merck Serono in 2010 as Medical Device innovation manager to strengthen product portfolio and contribute to the new generation of electronic devices. He was then appointed head of innovation in the newly created “Global Business Franchise Medical Devices” and got much more involved in business development and technology scouting in the space of digital health, AI & digital therapeutics. Eric joined a research organization in 2020 and co-founded a company called Epios, providing precision care for brain disorders enabled by implantable long-term brain sensing technology. In 2023, Eric joined back Merck as the head of device engineering and core team leader for connected pens.

• 

  Geraint Davies

  F. Hoffmann-La Roche

  Read Bio

  

  Geraint Davies

  F. Hoffmann-La Roche

  Geraint is a Principal Human Factors Engineer and Behaviour Design Specialist at Roche. He has 20 years experience of Medical Device and Digital Health development, and predominantly works on connected Medical Devices, SaMD, Digital Biomarkers and Digital Therapeutics. With a background in Product Design and more recent education in the behaviour sciences, Geraint focuses on bridging the gap between the opportunities offered by digital technology and the realities of human behaviour.

• 

  Gonçalo Farias

  Laboratory Manager for Nasal and Innovation Services, Aptar Pharma

  Read Bio

  

  Gonçalo Farias

  Aptar Pharma

  Gonçalo Farias is currently working as a Laboratory Manager for Nasal and Innovation Services at Aptar Pharma (France). He holds an MSc in Pharmaceutical Sciences from the University of Lisbon, Portugal (2014), and a Ph.D. in Pharmacy & Pharmacology from the University of Bath, UK (2021). During his PhD, he focused on the investigation of formulation design and structure of orally inhaled and nasal drug products (OINDPs) and his work has been published in peer-reviewed journals. Gonçalo Farias has 10 years of experience on OINDPs, and his previous roles were linked to analytical development, but also formulation and device product development.

• 

  Serkan Oray, PhD

  UCB Pharma

  Read Bio

  

  Serkan Oray, PhD

  UCB Pharma

  Serkan Oray leads an enterprise team within UCB covering development and industrialization of drug delivery systems, primary packaging, secondary packaging (including non-device products), and partnerships for digital and in vitro diagnostics. This team has grown organically over the last ten years, starting with the first subcutaneous drug delivery systems for UCB’s initial biologics portfolio and expanding to include additional modalities. Over this same period, Serkan’s team has been proud to be awarded multiple device design and packaging awards, including in the domain of sustainability. Prior to his work in device and packaging, Serkan’s career progressed through diverse functions at UCB, including medical affairs, commercial, and corporate strategy. He entered UCB in 2004 following an education in biomedical engineering and a PhD in Neuroscience from MIT.

• 

  Alain Regard

  Technology Product Manager, Nemera

  Read Bio

  

  Alain Regard

  Nemera

  Alain Regard is a Technology Product Manager of Insight by Nemera based in Lyon, France.

  Graduated in Polymer Engineering and Processing from Ecole Superieure de Plasturgie (ESP) in Oyonnax, France, Alain began his professional career as a design engineer in the automotive industry.

  He joined the Nemera in 2010 as a Product Development Leader working on multiple projects related to pumps, sprays and pMDIs. Alain, today at the position of Technology Product Manager leads the innovation and early-stage concepts research in the fields of nasal drug delivery. Alain has a track record of 14 published patent families in the field of drug delivery. His main fields of expertise are design of nasal drug dispensing devices, atomization, spray generation and characterization as well as Ear Nose and Throat (ENT) anatomy and physiology.

• 

  Mathias Romacker

  Kymanox

  Read Bio

  

  Mathias Romacker

  Kymanox

  Mathias Romacker was most recently Senior Director, Device Strategy at Pfizer HQ in New York City. He joined Pfizer in March 2015. In this commercial role, he focused on the front end of device technology. He worked with multiple functions and sites across the organization to develop a device strategy for Pfizer pipeline and inline products.

  Previously, for a duration of 9 years, Mathias worked in the device area for Amgen in Thousand Oaks, California. Before joining Amgen, he held multiple sales and marketing positions with Becton Dickinson and Gerresheimer in Germany, South Africa, and New Jersey. Mathias holds a Masters equivalent degree in economics from the University of Freiburg/Germany.

  Mathias is on the PDA Board of Directors.

• 

  Anand Subramony, PhD

  Eli Lilly & Company

  Read Bio

  

  Anand Subramony, PhD

  Eli Lilly & Company

  Anand Subramony is Vice President within the DDCS (Delivery, Device, and Connected Solutions) group at Eli Lilly and he provides leadership to early development of device combination products and novel drug delivery technologies. Prior to joining Lilly, Anand was Vice President within the Biologics Engineering and Targeted Delivery group, at AstraZeneca where he led various cross-functional teams and initiatives in the areas of nanomedicine -drug conjugates, and drug delivery of new modalities including implantable cell therapy devices. He also provided leadership to external innovation and CoSolve, an open innovation platform. Prior to that role Anand headed the Drug Delivery & Device Development at MedImmune/AZ and built an internal team that focused on combination product development, connected devices, digital biomarkers/sensors, as well as advanced novel delivery technologies including oral peptide delivery and other novel controlled release technologies. In other roles, Anand was Principal Fellow and Head of Novel Delivery Technologies at Novartis (NIBR, Cambridge, MA), head of the Materials Science group (E-TRANS) at Alza /J&J (Mountain View, CA), and Director of Materials Science & Drug delivery at Dr. Reddy’s Laboratories (Bridgewater, NJ). With his broad experience in pharma biotech, Anand brings innovation and scientific rigor coupled with execution excellence and sense of urgency to create patient centric products. He has established and managed high-performing teams in all his roles. Dr. Subramony holds an M.S. degree in Materials Science Engineering (IIT, Bombay) and a Ph.D. degree from Purdue University. With several refereed publications and patents, he is a sought-after Key Opinion Leader in the areas of drug delivery and product development.

• 

  Aaron Swick

  Senior Staff Engineer for Research and Development, Enable Injections

  Read Bio

  

  Aaron Swick

  Enable Injections

  As a Senior Staff Engineer for Research and Development at Enable Injections, Aaron Swick leads the connected healthcare program, driving collaborating with pharmaceutical partners to shape the evolution of enFuse technology. With over 15 years of experience in medical device and healthcare innovation, Mr. Swick leverages his extensive background in user and market research to steer product strategy and design. His diverse portfolio of work encompasses various healthcare technologies, including surgical instruments, diagnostics, capital equipment, consumer health and drug delivery products. He earned his MSE and BSE in Biomedical Engineering, and completed a post-graduate fellowship in medical innovation, all from the University of Michigan.

• 

  Paul Upham

  Roche/Genentech

  Read Bio

  

  Paul Upham

  Roche/Genentech

  Paul is the Head of Smart Devices at Roche / Genentech. Paul has 20+ years of experience in medical device R&D, strategic marketing, product management, clinical research, and medical informatics.

  Prior to Roche / Genentech, Paul was with Becton Dickinson(BD), as Worldwide Director of Strategic Marketing in their Pharmaceutical Systems business.

  Paul was also the head of Product at WellDoc, Inc., where he led the product management activities for WellDoc’s portfolio of mobile health solutions. He was responsible for WellDoc’s landmark BlueStar™ product, a class II medical device and the world’s first reimbursed, prescription-only software for diabetes.

  Paul’s prior experience includes 10 years in BD’s Diabetes Care business. Paul was responsible for the award-winning BD InterActiv® Diabetes Software, and was a member of the BD / Medtronic team that launched ParadigmLink®, the world’s first wireless blood glucose meter.

  Paul holds four issued patents in medical software and drug delivery devices and has multiple patent applications. He is also an author of numerous peer-reviewed articles in medical informatics and diabetes. His education includes undergraduate studies in cognitive science and graduate work in health informatics and finance at the University of Minnesota and New York University.

• 

  Markus Winderberg, PhD

  Head of Analytical Development, Microbiology, and Quality Control, LTS Lohmann Therapie Systeme

  Read Bio

  

  Markus Winderberg, PhD

  LTS Lohmann Therapie Systeme

  Markus is Head of Analytical Development, Microbiology, and Quality Control for the MAP-Program at LTS Lohmann Therapie Systeme AG in Andernach. He studied biology at Philipps University in Marburg, Germany, and was awarded a PhD in Parasitology in 2009 for his work on the membrane physiology and biochemistry of the Malaria parasite. From 2009 to 2015 he expanded his track record in infectious disease research at The Australian National University in Canberra, Australia. In 2015, he accepted a position for the University of Oxford, leading the Clinical Pharmacology laboratories at the Mahidol-Oxford Tropical Medicine Research Unit in Bangkok, Thailand. Markus has extensive experience in bio-analytics and infectious disease research with more than 30 peer-reviewed publications and more than $3.5M of competitive research funding over the past years. He participated in more than 30 clinical trials (phase 1 - 4), bioavailability and bioequivalence studies. In 2019 he joined LTS as Head of Analytical Development for the MAP Program. He has been heading the Microbiology and Quality Control for the MAP Program since 2021.

Presenters

• 

  Philippe Lauwers

  Terumo Pharmaceutical Solutions

  Read Bio
  

  Philippe Lauwers

  Terumo Pharmaceutical Solutions

  Philippe Lauwers has been active in the medical device and pharmaceutical packaging sector for the last fifteen years with growing responsibilities in business development and technical roles. He is currently the Director of Technology Development at Terumo Pharmaceutical Solutions in Belgium. Philippe graduated in Biotechnology from the University in Ghent, Belgium, and worked as a scientific researcher at the Catholic University of Leuven. Upon obtaining an additional degree in Biomedical Engineering at the Catholic University of Leuven he moved from an academic to an industrial environment. Philippe is a volunteer at the PDA organization and also serves as an expert in ISO technical committees TC76 and TC84

• 

  Andrei Yosef, PhD

  LTS

  Read Bio
  

  Andrei Yosef, PhD

  LTS

  Dr. Yosef ist the General Manager of LTS. 
  Leading expert in drug delivery device market and high end technologies. Dr Yosef applies his industry knowledge in both technology and business to steer forward Eitan Medical to develop and commercialize novel drug delivery device. Dr Yosef founded several startup companies in the field prior to him joining Q Core Medical. He served in several executive positions at Q Core for a decade, before taking the helm at pharmaceutical solutions of Eitan Medical including Sorrel’s wearable injectors products. Dr Yosef holds a PhD in Biomedical Engineering and an MA in Mechanical Engineering, both from the Technion – Israel Institute of technology.